Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page.

The Resilience Effect

As a company founded in science, the first thing we do when looking to address an issue is understand the data and see what it tells us. When we saw that persistent childhood adversity increases young people’s risk of developing a broad range of diseases, from asthma to heart disease and even Alzheimer’s, we knew we had to take action.

Stay in touch!

Enter your email to subscribe to our newsletter for updates on The Resilience Effect program and grantmaking.

Taking on Childhood Adversity

The consequences of adversity can last a lifetime – but they don’t have to. Children and communities can heal if support systems are in place – at home, in the community, at school, and in the doctor’s office.

Our goal is to improve the health and well-being of low-income children and families affected by adversity across the Bay Area through the pediatric healthcare system and the community settings that support it. To do that, we are funding organizations that together are creating an interdisciplinary approach to preventing and treating childhood adversity, including our newest initiative, the Resilient Beginnings Collaborative. Our support will focus on children under the age of five and their caregivers in low-income communities across the Bay Area.

In addition to providing grants, this program also enables our employees to lend their skills and time. We also encourage collaboration by convening our grantees, local government officials, and other health care, philanthropic and community-based organizations.

“The Resilience Effect is Genentech’s commitment to tackling a huge issue in public health – one that is unsung and under-appreciated. It’s an audacious goal to say we can prevent kids in our own backyard from developing the same diseases we come to work to find treatments for every day. But we like audacious goals.”

–Kristin Campbell Reed
Director, Corporate and Employee Giving

Current Grants and Programs

To date, we have invested more than $5 million to advance our goal across the following focus areas:

  • Clinical Care Improvement: Strengthening pediatric care environments and clinical services.
  • Family Engagement and Support: Improving family and community awareness of adversity, access to support, and continuity of care.
  • Research and Innovation: Driving the science forward to improve care quality and health outcomes across the Bay Area.
  • Sustainability and Scale: Sustaining services and addressing payment barriers.
  • Collective Action: Advancing collaboration and shared learning across the field.

To advance these impact areas, we are supporting a range of organizations through grants and skills-based volunteerism. Learn more about them here:

Resilient Beginnings Collaborative

In partnership with the Center for Care Innovations, Genentech Charitable Giving launched the Resilient Beginnings Collaborative, a learning program dedicated to addressing childhood adversity in pediatric safety net care settings.

The program supports the participation of seven Bay Area safety net clinics for 24 months with an aim to:

  • Strengthen organizational capacity to prevent and mitigate the effects of trauma in young children, taking a multigenerational approach;
  • Build on existing organization-led initiatives and interventions to address childhood adversity;
  • Enable organizations to further test, develop, and strengthen their role in addressing trauma and promoting resilience; and
  • Contribute to field-wide learning.

Click here to read more about the Resilient Beginnings Collaborative.

How can I get involved?

Sign up above for program and grantmaking updates. Currently, we are not accepting unsolicited proposals. Learn more about our other corporate giving priorities here: